Published in J Card Fail on June 01, 2001
Excessive daytime sleepiness is associated with poor medication adherence in adults with heart failure. J Card Fail (2010) 1.19
Gender-specific predictors of early mortality after coronary artery bypass graft surgery. Clin Res Cardiol (2012) 0.95
Self-rated health predicts healthcare utilization in heart failure. J Am Heart Assoc (2014) 0.92
Spiritual reconfigurations of self after a myocardial infarction: Influence of culture and place. Health Place (2010) 0.90
Modifiable factors associated with sleep dysfunction in adults with heart failure. Eur J Cardiovasc Nurs (2012) 0.89
Predictors of overall perceived health in patients with heart failure. J Cardiovasc Nurs (2013) 0.84
Overall perceived health predicts risk of hospitalizations and death in adults with heart failure: a prospective longitudinal study. Int J Nurs Stud (2012) 0.76
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med (2001) 7.05
The barbarism of managed care. Chest (1996) 4.57
www.journal? Chest (1997) 4.55
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Lancet (2000) 3.39
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension (2001) 3.16
Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med (1997) 3.13
Sleep apnea, hypopnea and oxygen desaturation in normal subjects. A strong male predominance. N Engl J Med (1979) 3.04
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation (1994) 2.74
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. N Engl J Med (1992) 2.72
N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation (1994) 2.05
Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med (2001) 1.93
Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J (2000) 1.88
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J (1999) 1.76
Headache in mild-to-moderate hypertension and its reduction by irbesartan therapy. Arch Intern Med (2000) 1.68
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol (1998) 1.67
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation (1994) 1.67
Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J Am Coll Cardiol (1990) 1.66
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. Circulation (1998) 1.63
Positive nasal airway pressure eliminates snoring as well as obstructive sleep apnea. Chest (1984) 1.63
[Adherence to guidelines in CHF therapy in Germany]. Dtsch Med Wochenschr (2005) 1.58
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study. Circulation (1982) 1.54
Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. Eur Heart J (1998) 1.52
Bronchial hyperresponsiveness to inhaled methacholine in subjects with chronic left heart failure at a time of exacerbation and after increasing diuretic therapy. Chest (1989) 1.52
The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure. Can J Cardiol (2003) 1.49
Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. Am J Med (1982) 1.46
Duplicate publication. Chest (1998) 1.45
Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction. Circulation (1998) 1.45
The results are not perfect. Chest (1999) 1.40
The quest for continual recertification. Chest (1994) 1.39
Bring back the ward laboratories. Chest (1993) 1.39
Dangerous sleep: oxygen therapy for nocturnal hypoxemia. N Engl J Med (1982) 1.39
What is a primary care physician? Chest (1994) 1.39
Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med (2001) 1.39
Is anyone paying attention? Chest (2001) 1.38
The education of a physician. Chest (1994) 1.38
Who will teach the medical students? Chest (1995) 1.36
Sleep-disordered breathing and nocturnal oxygen desaturation in postmenopausal women. Am J Med (1980) 1.29
Nocturnal pulmonary hypertension in patients with chronic obstructive pulmonary disease. Chest (1979) 1.29
Effect of compliance mismatch on vascular graft patency. J Vasc Surg (1987) 1.28
Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. Circulation (1995) 1.26
Lung injury from oxygen in lambs: the role of artificial ventilation. Anesthesiology (1969) 1.24
Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? Circulation (2001) 1.23
Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res (1991) 1.22
Disordered breathing and oxygen desaturation during sleep in patients with chronic obstructive lung disease (COLD). Am J Med (1979) 1.22
Fine needle aspiration (FNA) in HIV+ patients: results from a series of 655 aspirates. Cytopathology (1998) 1.21
Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol (2001) 1.21
A new approach for measuring quality of care for women with hypertension. Arch Intern Med (2001) 1.20
Prediction of postpneumonectomy pulmonary function using quantitative macroaggregate lung scanning. Chest (1974) 1.19
A trial of aerosolized theophylline in relieving bronchospasm. Chest (1976) 1.18
Topics in clinical medicine: serious complications and sudden death in the Pickwickian syndrome. Johns Hopkins Med J (1970) 1.17
Sleep apnea syndrome. A critical review of the apnea index as a diagnostic criterion. Chest (1984) 1.16
Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. Kidney Int (1986) 1.16
Do patients with sleep apnea die in their sleep? Chest (1988) 1.15
Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators. J Am Coll Cardiol (1997) 1.14
The influence of histamine and other vasoactive substances on contractile responses of cat skeletal muscle to acetylcholine. Br J Pharmacol (1973) 1.13
Assessment of psychosocial functioning of patients with sickle cell disease. South Med J (1988) 1.12
The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988--1994. J Clin Hypertens (Greenwich) (2001) 1.12
Alcohol increases sleep apnea and oxygen desaturation in asymptomatic men. Am J Med (1981) 1.11
Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysis. Am Heart J (2001) 1.09
Why does weight loss improve the respiratory insufficiency of obesity? Chest (1986) 1.09
Ambient oxygen tension modulates endothelial fibrinolysis. J Vasc Surg (1993) 1.09
Continuous in-vivo monitoring of arterial oxygenation in chronic obstructive lung disease. Ann Intern Med (1977) 1.09
Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation (1997) 1.08
Impact of poorly controlled hypertension on healthcare resource utilization and cost. Am J Manag Care (2001) 1.07
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design. Am Heart J (2000) 1.06
A new oxygen cannula system using intermittent-demand nasal flow. Chest (1978) 1.05
Incidence and natural history of left ventricular thrombus following anterior wall acute myocardial infarction. Am J Cardiol (1997) 1.04
Age and gender differences in excitation-contraction coupling of the rat ventricle. J Physiol (1998) 1.04
The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides (2000) 1.04
Prospective evaluation for pneumonectomy using the 99mtechnetium quantitative perfusion lung scan. Chest (1977) 1.03
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. Am Heart J (2000) 1.02
Clinical experience with epidural cooling for spinal cord protection during thoracic and thoracoabdominal aneurysm repair. J Vasc Surg (1997) 1.02
Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators. Circulation (1997) 1.02
Risk stratification after myocardial infarction using signal-averaged electrocardiographic criteria adjusted for sex, age, and myocardial infarction location. Circulation (1997) 1.01
Verapamil suppresses atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol (1983) 1.01
Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Immunopharmacology (1999) 1.01
Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect. Circulation (1985) 0.99
Neuropsychologic effects of continuous oxygen therapy in chronic obstructive pulmonary disease. Chest (1973) 0.99
Familial pulmonary capillary hemangiomatosis resulting in primary pulmonary hypertension. Ann Intern Med (1988) 0.99
Medroxyprogesterone acetate and COPD. Effect on breathing and oxygenation in sleeping and awake patients. Chest (1983) 0.99
Nocturnal vs diurnal cardiac arrhythmias in patients with chronic obstructive pulmonary disease. Chest (1979) 0.99
Modification of basal release of prostaglandins from rabbit isolated hearts. Prostaglandins (1974) 0.98
Consistency of respiratory measurements from night to night during the sleep of elderly men. Chest (1989) 0.97
The effect of weight loss on sleep-disordered breathing and oxygen desaturation in morbidly obese men. Chest (1982) 0.97
Amyotrophic lateral sclerosis presenting with respiratory failure. Diaphragmatic paralysis and dependence on mechanical ventilation in two patients. Chest (1977) 0.97
Is snoring a risk factor? Chest (1981) 0.96
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. J Am Coll Cardiol (1999) 0.96
Fatal pulmonary hemorrhage after transbronchial lung biopsy through the fiberoptic bronchoscope. Am Rev Respir Dis (1975) 0.96
Decreased coronary sinus oxygen content: a predictor of adverse prognosis in patients with severe congestive heart failure. J Am Coll Cardiol (1991) 0.96
Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity. Circulation (1986) 0.96
Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol (1994) 0.96
Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. Am J Cardiol (1984) 0.96
Delayed closure in lung abscess: a re-evaluation of the indications for surgery. Johns Hopkins Med J (1969) 0.95
Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy. Am Heart J (1988) 0.95